Form 4: Expensify CEO David Barrett Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Expensify's CEO, David Michael Barrett, executed multiple sales of Class A Common Stock between May 23 and May 31, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- David Michael Barrett, CEO of Expensify, Inc., sold shares of Class A Common Stock between May 23 and May 31, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on December 15, 2023.
- The transactions involved multiple sales at varying prices, ranging from $1.51 to $1.77 per share.
- A total of 60,150 shares were sold directly, reducing Barrett's direct holdings.
- Barrett indirectly owns 731,772 shares through Barrett Trust LLC.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine stock sales under a pre-arranged plan. It doesn't inherently indicate positive or negative performance for the company.
Risks
- The CEO's stock sales could be interpreted negatively by investors, potentially impacting the stock price.
- Continued sales under the 10b5-1 plan could exert downward pressure on the stock.
Future Outlook
The CEO's stock sales will continue under the existing 10b5-1 trading plan, but the specific timing and amounts are not detailed in this filing.
Industry Context
Executive stock sales are common and often pre-planned using 10b5-1 plans to avoid insider trading accusations. The impact on Expensify's stock will depend on investor perception and overall market conditions.
Comparison to Industry Standards
- Executive stock sales are a common practice across the industry, with many CEOs using 10b5-1 plans to manage their equity positions.
- Comparable companies like Bill.com and Coupa Software also see regular insider trading activity, often disclosed through Form 4 filings.
- The scale of these sales is relatively small compared to the overall market capitalization of Expensify.
Stakeholder Impact
- Shareholders may react to the CEO's stock sales, potentially influencing the stock price.
- The impact on employees, customers, suppliers, and creditors is likely minimal unless the sales trigger broader concerns about the company's financial health.
Key Dates
| Date | Description |
|---|---|
| 2023-12-15 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-05-23 | First transaction date |
| 2024-05-24 | Transaction date |
| 2024-05-28 | Transaction date |
| 2024-05-29 | Transaction date |
| 2024-05-30 | Transaction date |
| 2024-05-31 | Last transaction date and filing date |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.